hsc
LaboratoryInvestigation(2009)89,1152–1160&2009USCAP,IncAllrightsreserved0023-6837/09$32.00
TherapeutictargetingofthePDGFandTGF-b-signalingpathwaysinhepaticstellatecellsbyPTK787/ZK22258
YuqingLiu1,2,3,XiaoMingWen1,EricLikHangLui3,ScottLFriedman4,WeiCui2,NancyPeiShanHo2,LeiLi3,TaoYe1,2,SheungTatFan3andHuiZhang1,5
Stimulationofhepaticstellatecells(HSCs)byplatelet-derivedgrowthfactor(PDGF)andtransforminggrowthfactor-b1(TGF-b1)isanessentialpathwayofproliferationandfibrogenesis,respectively,inliverfibrosis.WeprovideevidencethatPTK787/ZK222584(PTK/ZK),apotenttyrosinekinaseinhibitorthatblocksvascularendothelialgrowthfactorreceptor(VEGFR),significantlyinhibitsPDGFreceptorexpression,aswellasPDGF-simulatedHSCproliferation,migrationandphosphorylationofERK1/2,Aktandp70S6kinase.Interestingly,PTK/ZKalsoantagonizestheTGF-b1-inducedexpressionofVEGFandVEGFR1.Furthermore,PTK/ZKdownregulatesTGF-breceptorexpression,whichisassociatedwithreducedAkt,ERKandp38MAPKphosphorylation.Furthermore,PDGF-inducedTGF-b1expressionisinhibitedbyPTK/ZK.ThesefindingsprovideevidencethatPTK/ZKtargetsmultipleessentialpathwaysofstellatecellactivationthatprovokeproliferationandfibrogenesis.OurstudyunderscoresthepotentialuseofPTK/ZKasanantifibroticdruginchronicliverdisease.
LaboratoryInvestigation(2009)89,1152–1160;doi:10.1038/labinvest.2009.77;publishedonline10August2009
KEYWORDS:Akt;HSC;PDGF;PTK787/ZK22258;TGF-b1
Liverfibrosisisapathologicalresponseofthelivertoavarietyofchronicstimuli.Hepaticstellatecells(HSCs)playanessentialroleinthedevelopmentofliverfibrosis.Afterchronicliverinjury,HSCsundergoaprocessofactivation,developingamyofibroblast-likephenotypethatproliferatesandbecomesfibrogenic1,2andproducesincreasedextra-cellularmatrixproteins.3
Severalcytokinemediatesarecentraltothefibroticpro-cess,includingplatelet-derivedgrowthfactor(PDGF)andtransforminggrowthfactor-b1(TGF-b1).PDGFisthemostpotentproliferativecytokinetowardHSCs,whereasTGF-b1primarilyfunctionsinthestimulationofextracellularmatrixproduction.3Intheliver,expressionofPDGFanditsre-ceptorsisincreasedbothinexperimentalfibrosisinratsandinhumanfibroticliver.4–6BothPDGF-BandPDGFR-barerapidlyinducedinvivoandinculture.4,7Moreover,thege-neticoverexpressionofPDGFleadstoliverfibrosisinmice.8Remarkably,veryfewstudieshaveassessedtheimpactof
1
PDGFantagonismonhepaticfibrosis.9Recentreportsusingimatinibmesylate(Gleevec)showpromise,10–12butitisuncertainwhetherPDGFRisitsmaintargetofactioninthesestudies.
TGF-b1isthemostpotentstimulustohepaticfibrogen-esis.13IncreasedlevelsofTGF-bhavebeendescribedinchronicliverdiseases,andactivatedHSCsrepresentamajorcellularsourceofTGF-bininjuredliver.InHSCs,TGF-bpromotesHSCtransformationintomyofibroblasts,simulatesthesynthesisofextracellularmatrixproteinsandinhibitstheirdegradation.AntagonismofTGF-b1signalingpathwaysmarkedlydecreasesfibrosisinexperimentalmodels.14,15
Becauseoftheircombinedrolesinfibrosis,inhibitingPDGFandTGF-b1signaltransductionisanattractivetargetforantifibrotictherapy.Anemergingstrategyistogeneratesmall-moleculeinhibitorsofreceptortyrosinekinasedo-mains.PTK787/ZK22258(PTK/ZK)isapotenttyrosinekinaseinhibitorofbothvascularendothelialgrowthfactor
LaboratoryofChemicalGenomics,SchoolofChemicalBiologyandBiotechnology,ShenzhenGraduateSchoolofPekingUniversity,Shenzhen,China;2DepartmentofAppliedBiology&ChemicalTechnology,TheHongKongPolytechnicUniversity,Kowloon,HongKong,China;3DepartmentofSurgery,TheUniversityofHongKong,Pokfulam,HongKong,China;4DivisionofLiverDiseases,MountSinaiSchoolofMedicine,NewYork,NY,USAand5CancerCellProteomics,NevadaCancerInstitute,LasVegas,NV,USA
Correspondence:DrYLiu,MD,PhDorProfessorHuiZhang,LaboratoryofChemicalGenomics,SchoolofChemicalBiologyandBiotechnology,ShenzhenGraduateSchoolofPekingUniversity,Shenzhen518055,ChinaorDrYLiu,MD,PhD,DepartmentofAppliedBiology&ChemicalTechnology,TheHongKongPolytechnicUniversity,Kowloon,HongKong,China.
E-mails:yuqing_liu@hotmail.comorzhanghui2006@szpku.edu.hk
Received3October2008;revised27May2009;accepted13June2009
1152
LaboratoryInvestigation|Volume89October2009|doc.guandang.net
of the signaling pathways regulating tumorigenesis, ...therapeutic perspective, because targeting them may ... angiopoietin-2 and PDGF, have been shown to ...
PDGF-D Signaling A Novel Target in Cancer ...PDGF-D appears to be a novel therapeutic target...Thus, these results suggest that targeting PDGF ...
The angiogenic mechanism and therapeutic potential of PDGF-CC, a recently discovered member of the VEGF/ PDGF superfamily, remain incompletely characterized. ...
肿瘤细胞分泌的 PDGF, angiopoietin 和 TGF 等还能...Therapeutic targeting of the tumor microenvironment.... basis of integrin regulation and signaling. ...
喜欢此文档的还喜欢 Therapeutic targeting of... 9页 免费搜你所想,读你所...signaling on cultured VSMCs and found that mechanical forces evoked activation...
and Small Ligands Targeting the GQuadruplex Tian ...attractive target for anti-cancer therapeutic agents... PDGF〔18〕以及 其他与人类某些疾病有密 切关系的...
Therapeutic targeting of BET bromodomain proteins in castration-resistant ...in metastatic prostate cancer: targeting the androgen receptor signaling pathway...
BMX represents a GSC therapeutic target and ...of STAT3 signaling in stem-like cancer phenotype...targeting BMX suppresses GSC tumor growth and ...
( PDGF) 等 ; 血管生成抑制因子有组织金属 蛋白酶... L ibutti SK Antiangiogenic therapy: targeting ...Integrin αβ3 as a therapeutic target for ...
PDGF, FGF, TGF-b 平滑肌细胞的增殖 动脉粥样硬化形成(atherogenesis)过程 的...长期抗血小板治疗以减少 动脉粥样血栓形成事件 Therapeutic targeting of platelets ...
热门文档